Stock OCX ONCOCYTE CORPORATION
Add to a list
To use this feature you must be a member
Log inSign up

Press Releases OncoCyte Corporation

Equities

OCX

US68235C2061

Market Closed - Nasdaq
Other stock markets
 01:30:00 21/06/2024 am IST 		5-day change 1st Jan Change
2.87 USD +6.69% Intraday chart for OncoCyte Corporation +5.13% +14.80%
18/06 OncoCyte Names Andrea James Chief Financial Officer MT
17/06 OncoCyte Corporation Appoints Andrea James as Chief Financial Officer CI

Press Releases

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Oncocyte Appoints Andrea James as Chief Financial Officer
AQ
OncoCyte's (NASDAQ:OCX) Innovative Approach: Potential in Precision Diagnostics
AQ
OncoCyte's Innovative Approach: Potential in Precision Diagnostics
AQ
Breakthrough in Kidney Transplant Monitoring: PRISM MarketView Spotlights Oncocyte's VitaGraft Study
AQ
Favorable Oncocyte VitaGraft Kidney Study Results Published in the New England Journal of Medicine
AQ
OncoCyte: Q1 Earnings Snapshot
AQ
Oncocyte Reports First Quarter 2024 Financial Results
AQ
Oncocyte to Announce First Quarter 2024 Financial Results
AQ
PRISM MarketView Spotlights Oncocyte Corporation as it Works to Disrupt the Precision Diagnostics Marketplace
AQ
ONCOCYTE REPORTS FULL YEAR 2023 FINANCIAL RESULTS
AQ
Oncocyte Corporation Announces $15.8 Million Private Placement of Securities Priced At-The-Market Under Nasdaq Rules
AQ
Oncocyte Reports Full Year 2023 Financial Results
AQ
Oncocyte Corporation Announces $15.8 Million Private Placement of Securities Priced At-The-Market Under Nasdaq Rules
AQ
Oncocyte : and Bio-Rad Partner on Global Launch of Transplant Assay - Form 8-K
PU
Oncocyte and Bio-Rad Partner on Global Launch of Transplant Assay
AQ
Oncocyte to Announce Fourth Quarter and Full Year 2024 Financial Results
AQ
Oncocyte to Present at the Sequire Investor Summit in Puerto Rico
AQ
Oncocyte Begins FDA Submissions Process for VitaGraft Transplant Assays
AQ
OncoCyte: Q3 Earnings Snapshot
AQ
Oncocyte Reports Third Quarter 2023 Financial Results
AQ
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. OCX Stock
  4. News OncoCyte Corporation
  5. Press Releases